Our impact

2019 was a huge year for advocacy at Emerge Australia. We can’t thank the ME/CFS community enough for getting behind so many campaigns and ensuring that your collective voice was heard.

Your actions enabled us to secure meetings with politicians across the political spectrum and have led to increased awareness of the challenges faced by people impacted by ME/CFS in Parliament.

2020 is shaping up to be even bigger.

Emerge Australia will continue to advocate for the inclusion of people with ME/CFS in telehealth services and increased access to the NDIS. We will deepen our relationships with the medical community to improve understanding of how to support patients living with ME/CFS. And we are working to increase support of grassroots advocacy at the State and Territory level.

Latest

Terms and Conditions of Purchase
Help us to educate people in power about ME/CFS

Help us to continue to improve our ability to educate people in power and people caring for those with ME/CFS
Research Digest 12/06/20

Welcome to the 49th edition of the Research Digest featuring a study investigating the role that Human herpesvirus 6A may play in ME/CFS pathogenesis and an Australian literature review on metabolomic dysregulation in ME/CFS.
Research Digest 29/05/20

Welcome to the 48th edition of the Research Digest featuring a study that investigates differences in immune gene SNP expression in ME/CFS and a systematic review on neurological impairments as measured by neuroimaging techniques.

Coronavirus and ME - Simplified facts

Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.
Research Digest 06/03/20

Welcome to the 42nd edition, featuring a study into a potential clinically-suitable diagnostic biomarker for ME/CFS and a study that furthers our knowledge of the mitochondrial dysfunction exhibited by ME/CFS patients.
Diagnosis

How a diagnosis of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) is made, the severity scale of ME/CFS, and the importance of early and accurate diagnosis
Accessibility
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
Research Digest 03/04/20

Welcome to the 44th edition of the Research Digest. This edition features a recently published book that highlights the value of biomedical research in ME/CFS and a systematic review into the effect of treatment interventions on pain scores in paediatric ME/CFS patients.
Research Digest 20/03/20

Welcome to the 43rd edition of the Research Digest. This fortnight's edition features two studies that investigate new approaches to the way ME/CFS can be diagnosed using microRNA analysis and fMRI.
What is fibromyalgia?

Fibromyalgia is an associated condition of ME/CFS
Research Digest 24/01/20

Welcome to the 39th edition, featuring a systematic review of ME/CFS randomized controlled trials and a study into the use of heart rate variability as a non-invasive biomarker for predicting fatigue severity in ME/CFS patients.
Research Digest 15/05/20

Welcome to the 47th edition of the Research Digest. This fortnight's edition digests a whole brain MRS study looking at metabolite abnormalities in the brains of ME/CFS patients and a French study investigating muscle excitability in exercising and resting muscles of patients diagnosed with ME/CFS.